Adding anticoagulation to thrombolytics for acute ischemic stroke (MOST trial)

There were lingering hopes that for patients with ischemic stroke, adding parenteral anticoagulation after thrombolytic therapy might improve outcomes. That line of inquiry might be at an end after the Multi-arm Optimization of Stroke Thrombolysis (MOST trial) reported phase 3 findings at the International Stroke Conference of the American Stroke Associ…